XML 126 R93.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Reporting - Schedule of Reconciliation to the Consolidated Net Income (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting, Revenue Reconciling Item [Line Items]      
Total revenue $ 358,711 $ 310,463 $ 331,339
Research and development 13,654 33,922 41,432
Amortization of acquired intangible assets 25,902 21,784 5,581
Changes in fair values of equity method investments, net 64,253 (77,392) 161,749
Changes in fair value of equity and long-term investments, net 59,161 (11,129) (8,462)
Interest and dividend income (19,141) (15,818) (6,369)
Interest expense 22,209 19,157 15,789
Gain on sale of Theravance Respiratory Company, LLC ("TRC") 0 0 (266,696)
Loss on extinguishment of debt 0 0 20,662
Other expense, net 2,997 4,969 3,373
Income tax expense, net 13,996 14,376 66,687
Net income 23,392 179,722 220,262
Operating Segments      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Total revenue 358,711 310,463 331,339
Selling and marketing 31,441 30,739 6,886
General and administrative 84,249 67,493 56,652
Amortization of acquired intangible assets 25,902 21,784 5,581
Changes in fair values of equity method investments, net 64,253 (77,392) 161,749
Changes in fair value of equity and long-term investments, net 59,161 (11,129) (8,462)
Interest and dividend income (19,141) (15,818) (6,369)
Interest expense 22,209 19,157 15,789
Gain on sale of Theravance Respiratory Company, LLC ("TRC") 0 0 (266,696)
Loss on extinguishment of debt 0 0 20,662
Other expense, net 2,997 4,969 3,373
Income tax expense, net 13,996 14,376 66,687
Net income 23,392 179,722 220,262
Amortization of inventory fair value adjustments | Operating Segments      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Cost of products sold 13,820 27,164 10,023
U.S. | Operating Segments      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Cost of products sold 10,921 7,535 2,488
Rest of the world | Operating Segments      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Cost of products sold 11,857 6,341 1,282
License      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Cost of license revenue 0 1,600 0
License | Operating Segments      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Cost of license revenue 0 1,600 0
External services | Operating Segments      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Research and development 7,408 20,051 24,666
Internal expenses | Operating Segments      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Research and development $ 6,246 $ 13,871 $ 16,766